NASDAQ:AIFF Firefly Neuroscience (AIFF) Stock Price, News & Analysis $1.75 +0.04 (+2.34%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$1.72 -0.02 (-1.43%) As of 05/22/2026 07:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Firefly Neuroscience Stock (NASDAQ:AIFF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Firefly Neuroscience alerts:Sign Up Key Stats Today's Range$1.70▼$1.7950-Day Range$1.50▼$3.0252-Week Range$0.62▼$3.77Volume167,230 shsAverage Volume390,936 shsMarket Capitalization$27.25 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Firefly Neuroscience is a clinical‐stage neurotechnology company focused on developing digital biomarkers and cognitive assessment tools for the early detection and monitoring of neurological disorders. The company’s platform combines mobile applications, sensor technology and advanced analytics to capture objective brain function data outside of traditional clinical settings. By providing real‐world cognitive and physiological measurements, Firefly aims to improve diagnosis, track disease progression and support therapeutic development. The company’s flagship offering is a smartphone‐based cognitive assessment app that guides users through a series of interactive tasks designed to measure attention, memory, processing speed and executive function. In select studies, Firefly has incorporated lightweight sensor headbands to record electroencephalogram (EEG) signals, enhancing its ability to derive neurophysiological biomarkers. These digital measures are intended both for clinical trial sponsors evaluating investigational treatments and for healthcare providers seeking earlier intervention strategies. Founded in 2017 and headquartered in the Greater Boston area, Firefly Neuroscience initially focused on Alzheimer’s disease and other forms of age‐related cognitive decline. The company collaborates with academic research centers, pharmaceutical partners and patient advocacy organizations to validate its tools across diverse populations. While its early clinical programs have been U.S.‐based, Firefly has signaled plans to expand its research partnerships and regulatory engagement in Europe and Asia. Firefly Neuroscience is led by a management team with backgrounds in neuroscience, medical device development and digital health innovation. Through its integrated hardware-software approach, the company seeks to redefine how brain health is assessed, moving beyond episodic, clinic-based testing to continuous, data-driven insights that can accelerate drug development and enhance patient care.AI Generated. May Contain Errors. Read More Firefly Neuroscience Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks6th Percentile Overall ScoreAIFF MarketRank™: Firefly Neuroscience scored higher than 6% of companies evaluated by MarketBeat, and ranked 283rd out of 297 stocks in the business services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingFirefly Neuroscience has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageFirefly Neuroscience has only been the subject of 1 research reports in the past 90 days.Read more about Firefly Neuroscience's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Firefly Neuroscience is -2.78, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Firefly Neuroscience is -2.78, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioFirefly Neuroscience has a P/B Ratio of 3.24. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Firefly Neuroscience's valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted7.39% of the float of Firefly Neuroscience has been sold short.Short Interest Ratio / Days to CoverFirefly Neuroscience has a short interest ratio ("days to cover") of 0.86, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Firefly Neuroscience has recently decreased by 21.87%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldFirefly Neuroscience does not currently pay a dividend.Dividend GrowthFirefly Neuroscience does not have a long track record of dividend growth. News and Social Media0.6 / 5News SentimentN/A Search Interest6 people have searched for AIFF on MarketBeat in the last 30 days. This is an increase of 50% compared to the previous 30 days. Company Ownership0.3 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Firefly Neuroscience insiders have not sold or bought any company stock.Percentage Held by Insiders6.44% of the stock of Firefly Neuroscience is held by insiders.Percentage Held by Institutions4.96% of the stock of Firefly Neuroscience is held by institutions.Read more about Firefly Neuroscience's insider trading history. Receive AIFF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Firefly Neuroscience and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AIFF Stock News HeadlinesFirefly Neuroscience (NASDAQ:AIFF) Upgraded to Hold at Wall Street ZenMay 16, 2026 | americanbankingnews.comFirefly Neuroscience Completes Additional Private Equity FinancingApril 22, 2026 | tipranks.comElon Musk’s $1 Quadrillion AI IPO$1 quadrillion would be enough to send a $2.8 million check to every man, woman, and child in America. That is the scale of what analysts are calling the biggest AI IPO in history.And right now, you can claim a stake before the company goes public, starting with just $500.Elon Musk is predicting this investment could climb 1,000x from here. Early access is available today. | Brownstone Research (Ad)Firefly Neuroscience Achieves Milestone with Over 200,000 EEG/ERP Brain Scans, Advancing AI-Driven Biomarker DiscoveryApril 13, 2026 | quiverquant.comQWith Brain Scan Volume Momentum Accelerating, Firefly Makes History by Building the World's First Known 200,000+ Standardized EEG/ERP DepositoryApril 13, 2026 | globenewswire.comFirefly Wins War Dept. Contract to Treat PTSDMarch 26, 2026 | baystreet.caWhy did AIFF stock surge over 20% pre-market today?March 26, 2026 | msn.comFirefly Neuroscience Partners with Department of War to Deploy AI-Powered EEG/ERP Technology for PTSD and TBI Support in U.S. Service MembersMarch 26, 2026 | quiverquant.comQSee More Headlines AIFF Stock Analysis - Frequently Asked Questions How have AIFF shares performed this year? Firefly Neuroscience's stock was trading at $0.8750 at the beginning of the year. Since then, AIFF stock has increased by 100.0% and is now trading at $1.75. How were Firefly Neuroscience's earnings last quarter? Firefly Neuroscience, Inc. (NASDAQ:AIFF) announced its earnings results on Tuesday, May, 12th. The company reported ($0.13) earnings per share (EPS) for the quarter. The company had revenue of $0.49 million for the quarter. Firefly Neuroscience had a negative trailing twelve-month return on equity of 94.68% and a negative net margin of 565.40%. When did Firefly Neuroscience's stock split? Firefly Neuroscience's stock reverse split on the morning of Tuesday, August 13th 2024.The 1-3 reverse split was announced on Friday, August 9th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Monday, August 12th 2024. An investor that had 100 shares of stock prior to the reverse split would have 33 shares after the split. How do I buy shares of Firefly Neuroscience? Shares of AIFF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Firefly Neuroscience own? Based on aggregate information from My MarketBeat watchlists, some other companies that Firefly Neuroscience investors own include Broadcom (AVGO), Paylocity (PCTY), Analog Devices (ADI), Advanced Micro Devices (AMD), ASML (ASML), Baidu (BIDU) and Bruker (BRKR). Company Calendar Last Earnings5/12/2026Today5/23/2026Next Earnings (Estimated)6/30/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (2m+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 AIFF's financial health is in the Green zone, according to TradeSmith. AIFF has been in this zone for over 2 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorBusiness Services Industry Technology Services Sub-IndustryComputer Software Current SymbolNASDAQ:AIFF Previous SymbolNASDAQ:AIFF CIK803578 Webfireflyneuro.com Phone(888) 237-6412Fax703-293-7979EmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)($0.63) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$19.88 million Net Margins-565.40% Pretax Margin-565.09% Return on Equity-94.68% Return on Assets-73.51% Debt Debt-to-Equity RatioN/A Current Ratio1.82 Quick Ratio1.78 Sales & Book Value Annual Sales$1.14 million Price / Sales23.90 Cash FlowN/A Price / Cash FlowN/A Book Value$0.54 per share Price / Book3.24Miscellaneous Outstanding Shares15,570,000Free Float14,569,000Market Cap$27.25 million OptionableN/A Beta0.60 7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free Report This page (NASDAQ:AIFF) was last updated on 5/23/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredThe AI stocks about to become worthless (and one that isn't)Louis Navellier - who manages $1.1 billion including $358 million in AI stocks - says a new AI computer being ...InvestorPlace | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Firefly Neuroscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Firefly Neuroscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
